Eric D. Babych
Shareholder
Overview

“I enjoy working with clients who are on the cutting edge of scientific innovation.”

Eric Babych has prepared and prosecuted countless patent applications in almost every country in the world. His international experience and perspective are invaluable to his U.S. and international clients who confront global issues every day, as well as those who are preparing for a future in the world marketplace. Thinking forward, Eric anticipates how protection strategies employed in one country will impact a patent’s strength half a world away, and develops approaches to minimize global risk.

A full-service patent lawyer, Eric has drafted freedom-to-operate, non-infringement, patentability and invalidity opinions, in addition to his prosecution work; and he has also provided support to various litigation teams. He has handled patent appeals before the United States Patent & Trademark Office and Oppositions before the European Patent Office.

As a former medicinal chemist and inventor, Eric speaks the language of his clients. While he handles a large amount of patent applications in the chemical and pharmaceutical arts, he also has significant experience working with mechanical inventions, medical devices, consumer products and electronics.

Education
  • J.D.,
    University of Dayton School of Law, 2007
  • B.S., Chemistry
    University of Utah, 2002
Bar Admissions
  • U.S. Patent & Trademark Office
  • Utah
Technical Background
  • Biopharma
Experience | Overview
  • Eric has prosecuted patent applications throughout North America, Asia, Europe, Africa, Australia, and South and Central America.
  • When a patent in Korea jeopardized the work of a U.S. client, Eric worked with Brinks Gilson & Lione’s local associate to institute and manage the ensuing Korean patent invalidation trial.
  • As a medicinal chemist, Eric conducted complex research focused on cardiovascular and neurological diseases. Some of the molecules he developed can be seen in International Patent Application No. PCT/US2004/043609, titled Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof.
Experience | Legal

Brinks Gilson & Lione
Associate, 2015-Present (Salt Lake City)
Associate, 2012-2014 (Chicago)

Ladas & Parry, Chicago, IL
Associate, 2008-2012

Experience | Non-Legal

Arena Pharmaceuticals, San Diego, Calif.
Medicinal Chemist, 2002-2004

Presentations
  • “An Overview of the America Invents Act,” IPA Spring Education Conference, Chicago, Illinois, May 16, 2013
Press Releases & Events
January 19, 2016

SALT LAKE CITY—Brinks Gilson & Lione, one of the nation’s largest intellectual property law ...

January 11, 2016

CHICAGO—Brinks Gilson & Lione, one of the nation’s largest intellectual property law firms, has elected eight attorneys ...

January 29, 2015
SALT LAKE CITY—Attorney Eric D. Babych of Brinks Gilson & Lione, one of the nation's largest intellectual property law firms, has moved to the firm's Salt Lake City office from Chicago. 'We're pleased to welcome Eric to ...
October 01, 2012
CHICAGO – Brinks Gilson & Lione, one of the largest intellectual property law firms in the United States, has announced the addition of six legal professionals in its Chicago office: Betsy J. Derwinski, Eric D. Babych, James G. DeRouin, ...
Honors
  • Summer Honors Program, 2004
  • Dean’s Scholarship Award, 2004-2007
Affiliations
  • American Chemical Society
  • American Intellectual Property Law Association
Back to Top